Cubist to Announce Second Quarter 2014 Financial Results on Tuesday, July 22, 2014
July 15 2014 - 9:00AM
Business Wire
Earnings Conference Call & Webcast at 5:00
pm ET
Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) will issue its
second quarter 2014 financial results at 4:00 p.m. ET on Tuesday,
July 22, 2014. In connection with this announcement, Cubist will
host a conference call and live audio webcast presentation at 5:00
p.m. ET that same day to discuss its second quarter financial
results, business activities, and financial outlook.
The quarterly earnings call will be available via phone and
webcast. The conference call dial-in information is listed below.
To access the webcast, please log on to the site at least 15
minutes prior to the start of the call to ensure adequate time for
any software downloads that may be required.
A replay of the webcast and teleconference will be available on
Cubist’s website beginning approximately three hours after the
call.
**************************CONFERENCE CALL &
WEBCAST INFORMATION**************************
CUBIST Q2 2014 FINANCIAL RESULTSTuesday, July
22, 2014 at 5:00 pm ET
U.S./Canada Attendee Dial-in: (855)
319-7654International Attendee Dial-in: (484) 756-4327Conference
ID: 55596186
24-HOUR REPLAY U.S./CANADA: (855)
859-205624-HOUR REPLAY INTERNATIONAL: (404) 537-3406Conference ID:
55596186
CALL WILL ALSO BE BROADCAST LIVE, LISTEN ONLY,
VIA THE WEB
AT:https://cubist.webex.com/cubist/onstage/g.php?t=a&d=625014646Attendee
Password: 07222014
Replay will be available for 90 days at
www.cubist.com
***************************************************************************************************************
About CubistCubist Pharmaceuticals, Inc. is a global
biopharmaceutical company focused on the research, development, and
commercialization of pharmaceutical products that address
significant unmet medical needs in the acute care environment.
Cubist is headquartered in Lexington, Massachusetts, with a central
international office located in Zurich, Switzerland. Additional
information can be found at Cubist’s web site at www.cubist.com.
Also, connect with Cubist on Twitter @cubistbiopharma and
@cubistcareers, LinkedIn, or YouTube.
Cubist Pharmaceuticals, Inc.INVESTORS:Eileen C. McIntyre, 781-860-8533Vice
President, Investor
Relationseileen.mcintyre@cubist.comorMEDIA:Julie DiCarlo, 781-860-8063Senior Director,
Corporate Communicationsjulie.dicarlo@cubist.com